chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This study case was received from the investigator on 04 April 2012. A 22-year-old male subject received the following vaccinations on 27 December 2011: an injection of ACAM2000 (lot number not reported) and TYPHIM VI, sanofi pasteur SA (lot number not reported). The subject had no significant medical history. On 09 January 2012, the subject had an abnormal troponin I of 11.05, an abnormal electrocardiogram (ECG) and an abnormal echocardiogram. On 08 January 2012, the subject was diagnosed with unspecified disease of pericardium and on 09 January 2012, the subject was diagnosed with acute pericarditis, unspecified. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
Day 1 excessive fussiness, no fever Day 2 pain swelling, redness at injection site tactile fever -later in day. Increased swelling and diffuse hives. Faded over course of almost 2 weeks. Office visit and Urgent Care Patient fell believed on immunization...to emergency. She has had what sounds like Exaggerated immune response to vaccine in the past according to Mother. As of 12/7/19 the Mother states Patient's symptoms have resolved. She is scheduled to see a pediatric allergist/immunologist tomorrow. The plan is to catch Patient up on her immunizations if decided safe
Allergic reaction to both ears/Rash with bumps on both ears and they're red; Allergic reaction to both ears/Rash with bumps on both ears and they're red; Allergic reaction to both ears/Rash with bumps on both ears and they're red; Allergic reaction to both ears/Rash with bumps on both ears and they're red; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205) via an unspecified route, administered in Left arm on 04Mar2021 at 13:00 (31-year-old at vaccination) as a Dose 1, Single for COVID-19 immunization. Facility type vaccine was reported as Pharmacy or Drug Store. Medical history was reported as none. No known allergies. There were no concomitant medications within two weeks of vaccination. The patient had not received any other vaccine in four weeks prior vaccination. The patient was not diagnosed with Covid prior vaccination. The patient was not tested for Covid post vaccination. On 06Mar2021 at 21:00, the patient experienced allergic reaction to both ears/rash with bumps on both ears and they're red. These adverse events did not result in emergency room/physician office visit. No treatment received for resulted events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information was expected.
Underdosed patient with pediatric dose.  Pt received CDC recommended correction at the same time and location
This spontaneous report as received from a Medical Assistant refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored VAQTA lot number N017094, expiration date 31-AUG-2018 (dose and route was not reported) for prophylaxis. No adverse effect was reported. Temperature: 9 grades Celsius to 25 grades Celsius "(10.1 C)". Time frame: 1 hour and 56 minutes. There was no previous temperature excursion involved. This is one of several reports received from the same source. Sender's Comments: US-009507513-1710USA003169: Original Case: 1710USA003115, US-009507513-1710USA003166: Original Case: 1710USA003115, US-009507513-1710USA003167: Original Case: 1710USA003115, US-009507513-1710USA003168: Original Case: 1710USA003115, US-009507513-1710USA003115: Original Case: 1710USA003115, US-009507513-1710USA003163: Original Case: 1710USA003115, US-009507513-1710USA003165: Original Case: 1710USA003115.
This spontaneous report as received from a pharmacist refers to a 69 years old female patient with no drug reactions/allergies. The patient was subcutaneously vaccinated at left arm with 0.65 ml ZOSTAVAX (Lot#/Exp:0363AE/16-MAR-2013) on 07-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that the patient experienced swelling and redness on her left arm, at the injection site after receiving ZOSTAVAX. He stated that the area had the appearance of an "insect bite". The patient had sought medical attention via coming back into the pharmacy. No lab diagnostics studies performed and no treatment was given for the AE. The outcome was reported as not recovered/not resolved. Additional information is not expected.
I started getting sick on 04/02/2023. I did not contact the doctor until that Tuesday because I did not realize it could be COVID-19. When I contacted the doctor, they suggested I take MUCINEX. They would not prescribe me PAXLOVID because of my kidney function.
This spontaneous report was received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unspecified date, in September 2015, reported as "sometime during the month of September 2015", the patients were vaccinated with unspecified improperly stored doses of PNEUMOVAX 23 lot #K008410 and expiration date 26-FEB-2016 and lot #L013428 expiration date 03-FEB-2017, (dose, route of administration and anatomical location were not provided). There were not concomitant medications reported. There was not product quality issue involved. This is one case of several cases from the same reporter. Additional information has been requested.
Pt received meningococcal and Tdap in right arm 10/9/12 - sometime before Halloween pt noticed she was breaking out in welts at night in that area. Itchy but self resolve - only happening at night.
Asthma; Cough; Really bad body aches; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  An adult female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 19Nov2021 (Lot number: FF2589) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN; Lot number: unknown; Route of administration: unspecified), for COVID-19 immunisation, reaction(s): "Drug ineffective"; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN; Lot number: unknown; Route of administration: unspecified), for COVID-19 immunisation, reaction(s): "Drug ineffective". The following information was reported: COUGH (non-serious) with onset 09Jan2022, outcome "unknown", described as "Cough"; PAIN (non-serious) with onset 09Jan2022, outcome "unknown", described as "Really bad body aches"; ASTHMA (non-serious) with onset 10Jan2022, outcome "unknown", described as "Asthma". The events "cough", "really bad body aches" and "asthma" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of asthma. No follow-up attempts are possible. No further information is expected.
When I awoke on  Saturday, 11/9/13 I had severe pain with any movement of my arm/shoulder.  On Wednesday, 11/13/13  I called my clinic and reported that I was still in significant pain and had very restricted range of motion in my arm.  I saw PA that day. She was on the phone with the CDC when I was in the office and told me she believed the pain and ltd ROM was the result of the vaccine being given too high in my arm.  On 11/20/13 the clinic recommended an ultrasound of the deltoid/muscles in my upper arm, and I had that done on 11/25/13. I was told the scan, which looked at my arm muscles but not my shoulder, was normal.  Dr. recommended physical therapy, and I started it on 12/2/13.  I was told that I had inflammation in the rotator cuff and what looked like a frozen shoulder.  I went to several PT appointments, was given and did exercises.  I consulted with an orthopedic doctor on 12/10/13, who confirmed that I had rotator cuff inflammation but said I did not have frozen shoulder.  Initially the PT seemed to help to a small degree, but by the end of December I found that even the gentle manipulation of PT made my arm ache for about 3 days afterwards.  I saw Dr. on 12/27/13.  He recommended a cortisone injection in my shoulder.  I received a cortisone injection from Dr. on 12/27/13.  After several days the pain subsided, almost disappeared for about a week, and then returned.  I saw Dr. and began acupuncture on 1/23/14.  I didn't get much relief from the first treatment.  I continue to have significant pain and very limited range of motion in my left arm.
had the Moderna shots in March and just had Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (had the Moderna shots in March and just had Covid) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (had the Moderna shots in March and just had Covid). At the time of the report, COVID-19 (had the Moderna shots in March and just had Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
t104 ax 24 hrs p/vax; inactive but alert-APAP/advil; sponge take temp q 4 hrs call MD; conditions became worse-fever persists;
Pt. received varicella et PPD on 6-14-11. Pt. presented 6-16-11 to have PPD read et notified nurse of possible reaction. Pt presented with a 5cm x 3.5cm area that is raised, red, et itching, surrounded by a pink parameter measuring 10cm x 7cm total. Area is tender touch and without warmth. Pt denies fever, nausea, et vomiting. Pt advised to use BENADRYL for itching et cold compress for pain.
pt recv vax & exp nausea, vomiting & itching;MD reported that on 6AUG96 pt n/v had resolved;pt itching is less;MD will administer DPH;
Severe leg pain Stiff neck x 2 days after the vaccine extream fatigue stomach pain no treatment
Sharp pain (R) shoulder, when arm flexed & rotated, raised above my head. Began immediately following shot.
No adverse event.  Reporting medication error.  Vial was prepared on 8/25/22 at 0900.  A vocational nurse prepared a dose of vaccine from the vial prepared/reconstituted on 8/25/22 and administered to her patient on 8/26/22.  The vial from 8/25 was not discarded per clinic policy and the nurse did not see the expired time labeled on vial.  Notified pharmacy of error.  Contacted CDC and Agency Pediatric Primary medical director.  Recommendation provided to the parent was to repeat the dose.  Parent notified and agreed to the plan of repeating the 2nd dose of 3 dose series.
I had a sore throat, severe headache, and a cough. I was in the hospital for 6 days.
two doses of Shingrix on the same day; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number 57LJ9, expiry date 14th April 2023) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 5th November 2021, the patient received the 2nd dose of Shingrix. On 5th November 2021, unknown after receiving Shingrix and Shingrix, the patient experienced overdose. On an unknown date, the outcome of the overdose was recovered/resolved.  Additional details were reported as follows; The health care professional called to request information on how to proceed after the patient had been given two doses of the Shingrix vaccine on the same day, which led to overdose. The reporter consented to follow up.
Dysgeusia; Loss of taste; Fever; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Dysgeusia), AGEUSIA (Loss of taste), PYREXIA (Fever) and MYALGIA (Body ache) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Dysgeusia), AGEUSIA (Loss of taste), PYREXIA (Fever) and MYALGIA (Body ache). At the time of the report, DYSGEUSIA (Dysgeusia), AGEUSIA (Loss of taste), PYREXIA (Fever) and MYALGIA (Body ache) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment medication were provided. Action taken for Moderna COVID-19 vaccine was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-076576 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076576:First Dose Case
My lest arm remains swollen and red, slightly itchy  at the injection site 11 days after my injection. I also developed a swollen lymph node in the armpit that remains tender and large. I read that this should only last 1-2 days so that is why I am reporting this.
Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). At the time of the report, CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.   Reporter did not allow further contact
RASH - 8cm x6cm raised red urticarial area on the right arm. Appears at the sight of the Menveo?
The day after my booster shot, I was at an appointment with my daughter, I took two steps out of the exam room and went down 3 times and then was sent by ambulance to the hospital. My blood pressure was 58/30 and pulse was 30. I received EKG and was given fluids, and diagnosed with a syncope. I was sent home that same day and received a full cardiac workup from my doctor. Echo Cardiogram and stress test all came back within normal range. I have not had another episode since. My arm was also swollen for a week post the vaccination. It did go away after a week's time.
The day that was 72 hours after having inoculated the Modern vaccine (2nd dose) I began to feel the sensation of not breathing completely, that is, a minimal sensation of having asthma but without shortness of breath, only that the breath could not reach the bottom , it was not complete. The first day after the vaccination (24 hours) and the 2nd day I only felt unusual headache, in the right ear, neck and different areas of the head, I controlled it with Tylenol 500mg.
Left arm injection site swelling, redness, hot to touch and pain. Nausea - HA. Resolved after 2 days. (1 inch needle used)
On 4/29/2021, I received my second  vaccination. Within 5 minutes, I had a strong metallic, sour taste in my mouth. It lasted for a couple of days. I had experienced the same taste when I got my first COVID vaccination on 4/8/2021, but this time it was stronger and longer-lasting than the first time. The first time, the flavor lasted for about a day, and it didn't kick in until about 30 minutes after the injection. Both times, I also had sore injection sites and fatigue. It basically felt like I had been punched in the arm. The sore arms and fatigue lasted for only a couple of days, and they didn't impede my ability to function. In 2016, I had a craniotomy, in which the upper and lower vestibular and cochlear nerves were removed. The only nerve now left is the facial nerve. This may have played a role in the formation of the strange taste, but I'm not sure. As of now, I have a sour taste in my mouth, but the metallic taste is gone. The neuroma has swollen as a result of the gamma knife radiation I received in February, so maybe it plays a role in the presence of the sour taste, but I don't know.
She got her vaccine, she had a slight fever on 1/19/22, then that night her arm was swollen where she got the vaccine, hard area.  She took liquid Tylenol.  The next day was still feverish but nothing major.  Then she was fine until 1/28/22, that day she went to work and she was having tingling on her like when you have too much caffeine, jittery feeling.  She was feeling hot (it's cold) and when she went outside she opened her jacket open and it felt good to be in the cold.  She was then hot when she went back into the office.  She went home and was not feeling well.  The next day she was not feeling good, had a rash with bumps, itching.  Her ears were swollen and pink and painful.  She had an allergic reaction and took a Zyzol.  Ever since the 29th, she had the rash all over her body and the heat wave comes and goes and when she has the jitteriness she knows she's going to break out somewhere.  She did go to a dermatologist who did not know what it was, and told her it was not an allergic reaction to food or animals and that she has seen it in some of her patient's who have had the vaccine.  She prescribed Prednisone and told her to take hot showers and use gentle soaps.  This did not help her, went to her PCP who did not know what to give her, and told her it would go away eventually.  She prescribed Prednisone again which she is having a reaction to and she told her to take more allergy pills.  She was told that there was nothing else that they can give her as they do not know what it is.    She has never had allergic reactions before, and also Prednisone is causing her lack of sleep.
Weakness in the left side of face; and fatigue. 1112 am went to observe patient in her room. Laying in the bed with left side droopiness to face. Weakness on left side only, nurse taking care of her stated just happened. On observation it appears to be Bells Palsy reaction. No treatment at the time, Hospice nurse is to visit her today and check on her. Staff will check on her every 30 min for the next few hours and do a pulse oximeter check every hour for next few hours. 1205 second check on patient in room prior to staff leaving. Patient squeezed my hand and opened her eyes on command. Pulse saturation was 95 per staff. Patient resting comfortable with no signs of trouble breathing.
COVID-19 Breakthrough. I had two symptoms. I had a sore throat for two days and lost my voice for one day and then I had a cough that lingered for two weeks.
This case was reported by a physician and described the occurrence of swollen buttocks in a 4-year-old male subject who was vaccinated with INFANRIX (GlaxoSmithKline). Previous and/or concurrent vaccination included IPV; Sanofi Pasteur MSD; unknown; unknown given on 25 March 2008. On 25 March 2008, the subject received 5th dose of INFANRIX (.5 ml, unknown). On 26 March 2008, 1 day after vaccination with INFANRIX, the subject experienced swollen buttocks. The physician believed there was a problem with this particular lot of INFANRIX. At the time of reporting the outcome of the events was unspecified.
pt recv vax 9AM 25FEB97 poss fever around 5PM; sz like episode (tonic/clonic) around 7AM;3-4min period of apnea requiring mouth to mouth resuscitation;cont fever & URI sx by 4PM 26FEB97;
This spontaneous report was received from a medical assistant concerning an unspecified patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date from 02-APR-2018 to 15-MAY-2018, the patient was vaccinated with an improperly stored dose of PROQUAD (Lot #: N021728, Exp Date:06-FEB-2019) (Lot#: N022972, Exp Date:19-FEB-2019), (Lot#: N029878, Exp Date: 22-APR-2019) or (Lot#: N025929, Exp Date: 18-MAR-2019) for prophylaxis, which had a temperature excursion of 6.1F for 5 minutes. Previous temperature excursion was 5.9 F for 45 minutes. The digital data logger was involved in recording the temperature excursion. The vaccine was reconstituted with properly stored dose of sterile diluent (MERCK) (no more information was provided). No adverse effect was reported. No product quality complaint was involved. This is one of the several reports from the same source. Sender's Comments:  US-009507513-1805USA009899:Original Case : 1805USA006787; US-009507513-1805USA009900:Original Case : 1805USA006787; US-009507513-1805USA009901:Original Case : 1805USA006787; US-009507513-1805USA009902:Original Case : 1805USA006787; US-009507513-1805USA009903:Original Case : 1805USA006787; US-009507513-1805USA009904:Original Case : 1805USA006787; US-009507513-1805USA006787:Original Case : 1805USA006787; US-009507513-1805USA009906:Original Case : 1805USA006787; US-009507513-1805USA009907:Original Case : 1805USA006787; US-009507513-1805USA009908:Original Case : 1805USA006787; US-009507513-1805USA009909:Original Case : 1805USA006787; US-009507513-1805USA009910:Original Case : 1805USA006787; US-009507513-1805USA009911:Original Case : 1805USA006787; US-009507513-1805USA009912:Original Case : 1805USA006787; US-009507513-1805USA009913:Original Case : 1805USA006787; US-009507513-1805USA009914:Original Case : 1805USA006787; US-009507513-1805USA009915:Original Case : 1805USA006787; US-009507513-1805USA009916:Original Case : 1805USA006787; US-009507513-1805USA009917:Original Case : 1805USA006787; US-009507513-1805USA009918:Original Case : 1805USA006787; US-009507513-1805USA009919:Original Case : 1805USA006787; US-009507513-1805USA009920:Original Case : 1805USA006787; US-009507513-1805USA009921:Original Case : 1805USA006787; US-009507513-1805USA009922:Original Case : 1805USA006787; US-009507513-1805USA009923:Original Case : 1805USA006787; US-009507513-1805USA009924:Original Case : 1805USA006787; US-009507513-1805USA009925:Original Case : 1805USA006787; US-009507513-1805USA009926:Original Case : 1805USA006787; US-009507513-1805USA009927:Original Case : 1805USA006787; US-009507513-1805USA009928:Original Case : 1805USA006787; US-009507513-1805USA009929:Original Case : 1805USA006787; US-009507513-1805USA009930:Original Case : 1805USA006787; US-009507513-1805USA009931:Original Case : 1805USA006787; US-009507513-1805USA009932:Original Case : 1805USA006787; US-009507513-1805USA009933.
No adverse events, vaccine listed as not recommended during pregnancy patient was 21 weeks at time of administration, EDD 11/22/2021
20 minutes post injection- generalized redness of skin,  felt hot and flushed. 25 minutes - tachycardia heart rate. Went from 60?s to 120?s. 30 minutes- difficulty swallowing and hypoxia @ 90
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: patient noticed redness and swelling on 08/09/2021 at the site of injection. was referred to see PCP or go to doctor for office visit. Patient insist its not problematic but had concerns from first dose of Moderna